Chemomab Therapeutics Ltd. Form 425: Prospectus or communication for a business combination
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-03-10: Form 425; Description FORM 8-K; Document tm218917d1_8k.htm.
- 2021-03-09: Form 425; Description 425; Document tm218933d1_425.htm.
- 2021-02-08: Form 425; Description FORM 8-K; Document tm215756d1_8k.htm.
- 2021-02-02: Form 425; Description 425; Document tm214843d1_425.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-03-10 | 425 | FORM 8-K | tm218917d1_8k.htm | |
| 2021-03-09 | 425 | 425 | tm218933d1_425.htm | |
| 2021-02-08 | 425 | FORM 8-K | tm215756d1_8k.htm | |
| 2021-02-02 | 425 | 425 | tm214843d1_425.htm | |
| 2021-01-11 | 425 | 425 | tm212120d1_425.htm | |
| 2021-01-05 | 425 | 425 | tm211612d1_425.htm | |
| 2011-11-07 | 425 | FORM 425 | form425.htm |